Clinical trial
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
NCT04580485
Study timeline
Study start (actual)2021-02-03Date precision: day
Registry last updated2025-07-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Ovarian Cancerunresolved
Bladder Cancerunresolved
Non Small Cell Lung Cancerunresolved
Squamous Cell Carcinoma of Head and Neckunresolved
Triple Negative Breast Cancerunresolved
Castration Resistant Prostate Cancerunresolved
Colorectal Cancerunresolved
Gastric/ Gastroesophageal Junctionunresolved
Hepatocellular Carcinomaunresolved
Pancreatic Ductal Adenocarcinomaunresolved
Squamous Carcinoma of the Anal Canalunresolved
Interventions
INCB106385DRUG
INCMGA00012DRUG
Sponsors & collaborators
Incyte Corporationlead sponsor
Mapped research locations
MadridSpain3LondonUnited Kingdom2New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1BaltimoreMaryland, United States1San AntonioTexas, United States1BarcelonaSpain1PittsburghPennsylvania, United States1ToulouseFrance1BrusselsBelgium1BuffaloNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04580485 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.